South Africa: Early treatment of HIV-infected infants with ART significantly reduces mortality - study

Treating HIV-infected infants with antiretroviral therapy (ART) as early as possible, within the first six to 12 weeks of life — rather than waiting until they show signs of immunological or clinical deterioration — dramatically decreases their risk of early death, according to findings from the Children with HIV Early Antiretroviral Therapy (CHER) trial, a South African study presented at a late-breaker session of the 4th International AIDS Society Conference on HIV Treatment and Pathogenesis in Sydney.